BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Endothelial cell
,
Metabolism of nitric oxide
,
Prozac
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FANCD2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bone marrow
Testes
Thymus gland
Tonsil
Subthalamic nucleus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Platelet count below reference range
Platelet disorder
Blood coagulation disorder
Anemia
Zika virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
n-hexanal
amitraz
Ecdysone
Interleukin-7
Diphenylamine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-34a-5p
ZNF131
MAP2K7
ERCC1
SLC16A2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.
FANCD2 knockdown with shRNA interference enhances the ionizing radiation sensitivity of nasopharynge…
TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage response.
Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 …
Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepato…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR)…
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurre…
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damag…
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ